Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Reliq Health Technologies Inc. (RHT) to present at Lytham Partners Summer 2021 Conference
  • CEO, Dr. Lisa Crossley, will deliver the company’s investor presentation and engage in a fireside chat session on Tuesday, June 15
  • The webcast will be archived and available for replay following the live event
  • Reliq Health Technologies is a rapidly growing global telemedicine company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market
  • Reliq Health Technologies Inc. (RHT) is down 3.16 per cent and is trading at C$0.46

Reliq Health Technologies Inc. (RHT) will participate in the Lytham Partners Summer 2021 Investor Conference from June 14-16.

Reliq’s CEO, Dr. Lisa Crossley, will deliver the company’s investor presentation and engage in a fireside chat session on Tuesday, June 15, 2021, at 3:30 pm ET.

The webcast will be archived and available for replay following the live event.

Dr. Crossley will also be available for one-on-one meetings throughout the event, which is scheduled for June 14 – 16, 2021. To arrange a meeting, please contact Lytham Partners at

Reliq Health Technologies is a rapidly growing global telemedicine company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market.

Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high-quality care at home, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery.

Reliq Health Technologies Inc. (RHT) is down 3.16 per cent and is trading at C$0.46.

More From The Market Herald

" Revive (CSE:RVV) gets FDA OK for Bucillamine trials to treat COVID-19

Revive Therapeutics (RVV), a cannabis and psychedelic healthcare company has received feedback from the U.S. FDA to help advance Bucillamine.
Nanalysis (TSXV:NSCI) - Founder & CEO, Sean Krakiwsky.

" Nanalysis (TSXV:NSCI) signs $160M security contract

Nanalysis Scientific (NSCI) has signed a six-year $160 million contract with Canadian Air Transportation Security Authority (CATSA).
Lifeist Wellness Inc - CEO, Meni Morim

" Lifeist Wellness (TSXV:LFST) announces sale of Swedish subsidiary Findify

Lifeist Wellness (LFST) announced the sale of Findify AB, the company’s Swedish subsidiary that operates an AI-powered product search and discovery platform.

" DIAGNOS (TSXV:ADK) testing autonomous AI solutions for diabetic retinopathy screening

Diagnos (ADK) is launching the testing phase for autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening.